Primary MALT Type Skin Lymphoma—Is ‘Wait and See’ a Possible Strategy?

Primary cutaneous lymphomas are the second most common site of extranodal non-Hodgkin lymphoma. A specifically type named extranodal marginal zone B-cell lymphomas are indolent low-grade neoplasma. We report a case of a 42-year-old white man with multiple subcutaneous tumors located on the trunk and...

Full description

Bibliographic Details
Main Authors: Florentina Silvia Delli, Thomas Zaraboukas, Ioanna Mandekou-Lefaki
Format: Article
Language:English
Published: SAGE Publishing 2008-01-01
Series:Clinical Medicine Insights: Oncology
Online Access:https://doi.org/10.4137/CMO.S336
id doaj-b59edc3a7c714ea0939f643bb0805437
record_format Article
spelling doaj-b59edc3a7c714ea0939f643bb08054372020-11-25T03:15:24ZengSAGE PublishingClinical Medicine Insights: Oncology1179-55492008-01-01210.4137/CMO.S336Primary MALT Type Skin Lymphoma—Is ‘Wait and See’ a Possible Strategy?Florentina Silvia Delli0Thomas Zaraboukas1Ioanna Mandekou-Lefaki2Dermatology Department, Private Practice, Thessaloniki, Greece.Anatomopathology Department, Aristotle University of Thessaloniki, Greece.Dermatology Department, State Hospital for Skin and Venereal Diseases, Thessaloniki, Greece.Primary cutaneous lymphomas are the second most common site of extranodal non-Hodgkin lymphoma. A specifically type named extranodal marginal zone B-cell lymphomas are indolent low-grade neoplasma. We report a case of a 42-year-old white man with multiple subcutaneous tumors located on the trunk and neck. The histopathological exam showed a non-epidermotropic, dense lymphocytic infiltrate. Histologic, immunohistochemical and cytologenetic analysis diagnosed primary cutaneous B-cell lymphoma MALT type. Investigation for other extranodal MALT lymphoma gastrointestinal tract, lung, salivary and thyroid glands was negative. The patient refused radiotherapy, but he accepted every 6 months close follow-up. Over a seven years period, we noticed a progressively disappearance of the skin lesions. The necessity of aggressive treatment of this disease with excellent prognosis is discussed. The treatment necessity of primary cutaneous B-cell lymphoma MALT type is discussed.https://doi.org/10.4137/CMO.S336
collection DOAJ
language English
format Article
sources DOAJ
author Florentina Silvia Delli
Thomas Zaraboukas
Ioanna Mandekou-Lefaki
spellingShingle Florentina Silvia Delli
Thomas Zaraboukas
Ioanna Mandekou-Lefaki
Primary MALT Type Skin Lymphoma—Is ‘Wait and See’ a Possible Strategy?
Clinical Medicine Insights: Oncology
author_facet Florentina Silvia Delli
Thomas Zaraboukas
Ioanna Mandekou-Lefaki
author_sort Florentina Silvia Delli
title Primary MALT Type Skin Lymphoma—Is ‘Wait and See’ a Possible Strategy?
title_short Primary MALT Type Skin Lymphoma—Is ‘Wait and See’ a Possible Strategy?
title_full Primary MALT Type Skin Lymphoma—Is ‘Wait and See’ a Possible Strategy?
title_fullStr Primary MALT Type Skin Lymphoma—Is ‘Wait and See’ a Possible Strategy?
title_full_unstemmed Primary MALT Type Skin Lymphoma—Is ‘Wait and See’ a Possible Strategy?
title_sort primary malt type skin lymphoma—is ‘wait and see’ a possible strategy?
publisher SAGE Publishing
series Clinical Medicine Insights: Oncology
issn 1179-5549
publishDate 2008-01-01
description Primary cutaneous lymphomas are the second most common site of extranodal non-Hodgkin lymphoma. A specifically type named extranodal marginal zone B-cell lymphomas are indolent low-grade neoplasma. We report a case of a 42-year-old white man with multiple subcutaneous tumors located on the trunk and neck. The histopathological exam showed a non-epidermotropic, dense lymphocytic infiltrate. Histologic, immunohistochemical and cytologenetic analysis diagnosed primary cutaneous B-cell lymphoma MALT type. Investigation for other extranodal MALT lymphoma gastrointestinal tract, lung, salivary and thyroid glands was negative. The patient refused radiotherapy, but he accepted every 6 months close follow-up. Over a seven years period, we noticed a progressively disappearance of the skin lesions. The necessity of aggressive treatment of this disease with excellent prognosis is discussed. The treatment necessity of primary cutaneous B-cell lymphoma MALT type is discussed.
url https://doi.org/10.4137/CMO.S336
work_keys_str_mv AT florentinasilviadelli primarymalttypeskinlymphomaiswaitandseeapossiblestrategy
AT thomaszaraboukas primarymalttypeskinlymphomaiswaitandseeapossiblestrategy
AT ioannamandekoulefaki primarymalttypeskinlymphomaiswaitandseeapossiblestrategy
_version_ 1724639655993802752